
Psychiatric News | J Fontan/Getty/iStock
While ECT is a highly effective intervention for treatment-resistant depression, utilization is low in part because of patient concerns about adverse cognitive effects as well as the resources required (for example, needing a psychiatrist and anesthesiologist for each procedure). Relatedly, the short-term efficacy of ketamine for treatment-resistant depression has been well established, but there have been no longer-term studies assessing both its effectiveness and cost.